Original Research
Accepted on 14 Jan 2026
The Effect of Scheduled Metamizole on Opioid Consumption after Cardiac Surgery
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
- 114 views
Type at least 3 characters
2,248 articles
articles
Original Research
Published on 14 Jan 2026
A comprehensive analysis of dry eye disease clinical trials (2000–2024): research trends and gaps
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2026.1713433
- 326 views
Original Research
Accepted on 13 Jan 2026
Estimating real-world treatment effects in the presence of measurement error and sparse outcome data using propensity score methods
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
Original Research
Accepted on 12 Jan 2026
A study on the availability of national centralized drug procurement in regions with different levels of economic development: An investigation and analysis of 31 provincial-level administrative regions in China
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
- 100 views
Original Research
Published on 12 Jan 2026
Clinical outcomes of adverse drug reaction-related hospital admissions in older adults with diabetes
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1729848
- 274 views
Systematic Review
Published on 12 Jan 2026
Melatonin supplementation reduces delirium incidence in critically ill patients: a systematic review and meta-analysis
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2026.1728873
- 270 views
Original Research
Published on 09 Jan 2026
Drug shortage in South Korea: machine learning-based prediction models and analysis of duration and causal factors
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1608843
- 810 views
Original Research
Published on 08 Jan 2026
Economic value of extended-window intravenous alteplase in posterior circulation stroke: a Markov analysis based on the EXPECTS trial
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1734165
- 811 views
Original Research
Published on 08 Jan 2026
Challenges of benzodiazepine deprescribing in elderly patients attending primary healthcare
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1729081
- 417 views
Original Research
Published on 08 Jan 2026
Quantifying structural selection bias in observational cohort data: a ponderation analysis of age - specific incidence rates to inform vaccine safety verification
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1754809
- 410 views
Original Research
Published on 08 Jan 2026
Adherence to denosumab therapy and all-cause mortality in dialysis patients with osteoporosis: a retrospective cohort exploratory study
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1708051
- 462 views
Original Research
Accepted on 07 Jan 2026
A Study on the Accessibility and Utilisation of Targeted Drugs for Pulmonary Arterial Hypertension in China
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
- 148 views
Systematic Review
Accepted on 07 Jan 2026
The incidence of chronic drug-induced liver injury: A systematic review and meta-analysis
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
- 135 views
Original Research
Accepted on 07 Jan 2026
Evaluating a Multifaceted Stewardship Intervention on Proton Pump Inhibitor Utilization: An Interrupted Time Series Analysis of Prescribing Patterns in a Northwest Chinese Hospital
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
Systematic Review
Published on 07 Jan 2026
Subcutaneous versus intravenous trastuzumab for HER2-positive breast cancer: a global systematic review and meta-analysis with a cost-minimization analysis from the Chinese healthcare system perspective
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1730175
- 434 views
Original Research
Published on 07 Jan 2026
Association between vancomycin therapeutic drug monitoring and improved clinical outcomes in critically ill patients receiving renal replacement therapy: a retrospective cohort study
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1715023
- 417 views
Original Research
Published on 06 Jan 2026
Real-world clinical outcomes of EKOS catheter-directed thrombolysis versus systemic alteplase in acute pulmonary embolism: a retrospective cohort study
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1709708
- 536 views
Original Research
Published on 06 Jan 2026
Patients’ experiences and practices of medication literacy in inflammatory bowel disease: a qualitative study
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1726618
- 356 views
Systematic Review
Accepted on 05 Jan 2026
Clinical Trial Characteristics and Intervention Profiles for Mild Cognitive Impairment: A systematic analysis of WHO ICTRP Registry
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
- 120 views
Review
Published on 05 Jan 2026
Epilepsy, neuroinflammation and cannabidiol What do we know thus far?
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1749260
- 792 views
Original Research
Accepted on 02 Jan 2026
Risk Perception and Influenza Vaccine Hesitancy among University Students in Saudi Arabia
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
- 181 views
Original Research
Published on 02 Jan 2026
A cost-effectiveness analysis of baloxavir marboxil versus oseltamivir for seasonal influenza treatment in China
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1697645
- 593 views
Original Research
Accepted on 31 Dec 2025
Analysis of Susceptibility Factors for Heparin-Induced Thrombocytopenia (HIT) in Patients Undergoing Hemodialysis
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
- 166 views
Review
Accepted on 29 Dec 2025
Incorporating Patient-Reported Outcome Measures into routine paediatric pharmacovigilance: opportunities for safety monitoring with practical use scenarios from paediatric oncology
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
- 106 views